SCHEMBL23164

SCHEMBL23164

CC(C)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15638641 1.00
Ammonia Solution, Strong SCHEMBL25012 0.95
Hydrochloric Acid SCHEMBL30382208 0.95
SCHEMBL772806 0.74
SCHEMBL12552650 0.74 ALDH1A1 (0.33)
SCHEMBL25028393 0.74 ALDH1A1 (0.31)
SCHEMBL24871 0.74
SCHEMBL1172952 0.74
Water SCHEMBL1116143 0.74
SCHEMBL799182 0.74 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2873 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568977-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF GELEST, INC. (US) 2025-06-18 EP claimed
WO-2025090723-A1 HYDROFLUOROCARBON COMPOUNDS AND THEIR USE IN INTEGRATED CIRCUIT MANUFACTURING PROCESSES VERSUM MATERIALS US, LLC (US) 2025-05-01 WO claimed
US-11970485-B2 RET kinase inhibitors ELI LILLY AND COMPANY (US) 2024-04-30 US claimed
US-11964968-B2 Compounds useful for inhibiting RET kinase ELI LILLY AND COMPANY (US) 2024-04-23 US claimed
US-20240116854-A1 CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH INTERVET INC. (US) 2024-04-11 US claimed
US-20240109866-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2024-04-04 US claimed
US-20240083917-A1 Polycyclic Kinase Inhibitor Xuanzhu Biopharmaceutical Co., Ltd. (CN) 2024-03-14 US claimed
CN-115461338-B 3-azabicyclo (3.1.0) hexane derivatives having KDM5 inhibitory activity and uses thereof 小野药品工业株式会社 2024-02-20 CN claimed
WO-2024035914-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF GELEST, INC. (US) 2024-02-15 WO claimed
WO-2024012557-A1 ANTI-APOPTOTIC BCL-2 FAMILY PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BERRYBIO (HONG KONG) LIMITED (CN) 2024-01-18 WO claimed
EP-0042291-B1 METHODS AND COMPOSITIONS FOR PREPARATION OF H-ARG-X-Z-Y-TYR-R ORTHO PHARMACEUTICAL CORPORATION (US) 1986-12-10 EP claimed
EP-0018793-B1 PEPTIDES AND PROCESS FOR THEIR PREPARATION ORTHO PHARMACEUTICAL CORPORATION (US) 1983-11-09 EP claimed
EP-0043219-B1 IMMUNOREGULATORY DIKETOPIPERAZINE COMPOUNDS ORTHO PHARMACEUTICAL CORPORATION (US) 1983-10-05 EP claimed
US-4369137-A N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide ORTHO PHARMACEUTICAL CORPORATION (US) 1983-01-18 US claimed
US-4331595-A Immunoregulatory diketopiperazine compounds ORTHO PHARMACEUTICAL CORPORATION (US) 1982-05-25 US claimed
EP-0043219-A1 Immunoregulatory diketopiperazine compounds ORTHO PHARMACEUTICAL CORPORATION (US) 1982-01-06 EP claimed
EP-0042291-A2 Methods and compositions for preparation of H-Arg-X-Z-Y-Tyr-R ORTHO PHARMACEUTICAL CORPORATION (US) 1981-12-23 EP claimed
US-4298523-A OLIGOPEPTIDES OF ARGININE, LYSINE, VALINE, SARCOSINE, ASPARTIC OR GLUTAMIC ACID, AND TYROSINE ORTHO PHARMACEUTICAL CORPORATION (US) 1981-11-03 US claimed
US-4250086-A Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2 ORTHO PHARMACEUTICAL CORPORATION (US) 1981-02-10 US claimed
EP-0018793-A2 Peptides and process for their preparation ORTHO PHARMACEUTICAL CORPORATION (US) 1980-11-12 EP claimed